Response to Why Addiction is NOT a Brain Disease

In a thoughtful post, Marc Lewis questions the disease model of addiction. He doesn't dismiss it out of hand. He seems to look for ways in which it's right and useful. It’s accurate in some ways. It accounts for the neurobiology of addiction better than the “choice” model and other contenders. It explains the helplessness … Continue reading Response to Why Addiction is NOT a Brain Disease

Cognitive performance of opioid maintenance vs. abstinence

  A new study finds lower cognitive functioning in maintenance patients compared with abstinent former users. It also found no difference between methadone patients and buprenorphine patients.   Background To compare the cognitive performances of maintenance patients (MAIN), abstinent ex-users (ABST) and healthy non-heroin using controls (CON). Methods Case control study of 125 MAIN (94 … Continue reading Cognitive performance of opioid maintenance vs. abstinence

Treatment is big money

From Alcoholism and Drug Abuse Weekly: In September, when Tennessee-based Acadia Healthcare Company paid $90 million for Timberline Knolls, a 122-bed inpatient treatment program in Chicago, treatment providers wondered if their programs were worth that kind of money, bed for bed. Other deals in recent months, including Foundations Recovery Network’s acquisition in early October by … Continue reading Treatment is big money

Acomprosate – A Randomized, Double-Blind, Placebo-Controlled Study

Recently published and found no "evidence of efficacy for acamprosate compared to placebo". However, "A goal of abstinence was significantly associated with improved drinking outcomes". Efficacy of Acamprosate for Alcohol Dependence in a Family Medicine Setting in the United States: A Randomized, Double-Blind, Placebo-Controlled Study Background Acamprosate has been found to enhance rates of complete … Continue reading Acomprosate – A Randomized, Double-Blind, Placebo-Controlled Study

NAATP launches counteroffensive to medication push

This is very welcome news: Frustrated that medication-assisted treatment is coming across as the addiction field’s standard of care simply because drug company studies are dominating the research landscape, a group of some of the most prominent leaders in treatment administration is vowing to fight back. These leaders have enlisted the help of another heavy … Continue reading NAATP launches counteroffensive to medication push

Methadone and employment

These findings were characterized as "counterintuitive". Findings from multivariate analyses initially showed no association between treatment enrollment and employment transitions. However, when a distinction was made between MMT and other addiction treatment modalities, it became clear that the relationship between addiction treatment and employment outcomes for IDU in this setting was contingent upon the type … Continue reading Methadone and employment